When was Sequential Bio founded?

Sequential Bio was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Where is Sequential Bio located?

Sequential Bio is headquartered in New York City, United States.

Who is the current CEO of Sequential Bio?

Oliver Worsley of Sequential Bio. They have also founded 1 company.

Which legal entities is Sequential Bio associated with?

Sequential Bio is associated with SEQUENTIAL SKIN LTD and 1 other.

How many employees does Sequential Bio have?

As of Jul 01, 2024, the latest employee count at Sequential Bio is 4.

Is Sequential Bio a funded company?

Sequential Bio is a funded company, having raised a total of $7.5M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 17, 2021.

When was the latest funding round of Sequential Bio?

Sequential Bio's latest funding was a $***** Series A round on Mar 17, 2026, with participation from 5 investors.

Where does Sequential Bio rank among its competitors?

Sequential Bio ranks 1st amongst 5 active competitors, of which 3 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Sequential Bio, which secured $3.5M in Mar, 2026.

Who are the top competitors of Sequential Bio?

Sequential Bio's top competitors include Parallel Health, Sapere Bio and Eykona Technologies. Among them, Sequential Bio secured the most recent funding round in March, 2026.

Sequential Bio - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of in-vivio microbiome testing platform for skin care. The company offers at-home skin microbiome tests, through the Sequential Skin patch for skin care, scalp care, intimate care, or oral care.

Key Metrics

Founded Year

2019

Location

New York City, United States

Stage

Series A

Total Funding

$7.5M in 6 rounds

Latest Funding Round

Series A, Mar 17, 2026, $*****

Investors

IndieBio & 10 more

Ranked

1^st among 5 active competitors

Employee Count

4 as on Jul 01, 2024

Similar Companies

Cherry Imaging & 27 more

View Sequential Bio's full profile

Sequential Bio is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SEQUENTIAL SKIN INC. CIN: 6392583 , United States, Active	Nov 29, 2021	-	-	-
SEQUENTIAL SKIN LTD CIN: 12547483 , United Kingdom, Active	Apr 05, 2020	-	4 (As on Mar 31, 2025)

Sequential Bio has raised a total funding of $7.5M over 6 rounds. Its first funding round was on Mar 17, 2021. Its latest funding round was a Series A round on Mar 17, 2026 for $*****. 5 investors participated in its latest round. Sequential Bio has 8 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of Sequential Bio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 17, 2026	4497588	Series A	6766502	9785298	4739825	1948783
May 25, 2023	8153983	Seed	7111834	7074968	9263559	Corundum Systems Biology
Oct 2022	9567438	Seed	9090460	5154239	6427188	Corundum Systems Biology

Access funding benchmarks and valuations. Sign up today!

View details of Sequential Bio's funding rounds and investors

The founders of Sequential Bio are Oliver Worsley and Albert Dashi. Oliver Worsley is the CEO of Sequential Bio.

Here are the details of Sequential Bio's key team members:

Oliver Worsley: Co-Founder & CEO of Sequential Bio and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address
Albert Dashi: Co-Founder of Sequential Bio and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address

Sequential Bio's Board of Directors

Sequential Bio's board has 2 active members. Oliver Worsley and Albert Dashi are part of team.

Here is the list of Sequential Bio's board of directors:

Name	Type	Representing	Status	Duration
Oliver Worsley	Team	-	Current	6y 2m
wsnimsk	Team	-	Past	1y 6m

View details of Sequential Bio's Founder profiles and Board Members

Sequential Bio's employee count trend

Sequential Bio has 4 employees as of Jul 24. Here is Sequential Bio's employee count trend over the years:

Uncover Sequential Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sequential Bio include Parallel Health, Sapere Bio and Eykona Technologies. Here is the list of Top 10 competitors of Sequential Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sequential Bio 2019, New York City (United States), Series A	Provider of in-vivio microbiome testing platform for skin care	$7.5M	Metaplanet, SOSV & 9 others	58/100
2nd	Parallel Health 2020, San Francisco (United States), Seed	Provider of microbiome based test for personalized skin care products	-	Illumina, Agile Angel & 4 others	31/100
3rd	Sapere Bio 2013, Raleigh (United States), Seed	Diagnostic company that develops non-invasive biomarker tests to measure cellular aging and predict the risk of age-related diseases	$500K	HHS	28/100
4th	Eykona Technologies 2007, Oxford (United Kingdom), Late Stage	Provider of portable 3D imaging systems for dermatological applications	$1.86M	MTI Partners, Parkwalk & 4 others	27/100
5th	Milieu 2024, Ann Arbor (United States), Funding Raised	Developer of skincare products and microbiome analysis for personalized skin health	-	Boost VC	19/100